Waystar Weighs Sale Amidst Market Challenges, Sources Reveal
Healthcare software firm Waystar is considering a sale, two years after its IPO, as its market value drops.
Waystar, a prominent player in healthcare software, is reportedly exploring strategic options, including a potential sale, according to sources familiar with the matter. This comes two years after the company went public on the New York Stock Exchange. The firm, which operates out of Lehi, Utah, and Louisville, Kentucky, has enlisted investment bank Evercore to guide the process, insiders disclosed.
Waystar specializes in providing technology solutions that automate administrative tasks for healthcare providers, aiming to capitalize on the higher valuations typically associated with tech companies. Despite its strategic positioning, Waystar's valuation has suffered a setback, currently estimated at approximately $4.8 billion following a 24% decline in share price this year. This downturn aligns with a broader selloff in the software sector.
Investment Strategies and Challenges
Initially, Waystar's technology-focused approach resonated well with investors, driving its stock from $20 to a peak of $45 in 2025. However, recent concerns about potential disruptions from advancements in artificial intelligence have pressured the stock, as noted by Morgan Stanley analysts in a July report.
Waystar was formed through a 2017 merger of healthcare revenue management companies Zirmed and Navicure. The company's major stakeholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital, with EQT holding the largest share at 13%. CPPIB and BlackRock Institutional Trust Company hold 10% and 8% stakes, respectively, according to LSEG data.
Potential Sale and Market Reaction
While the discussions are still in the early stages, and a sale is not guaranteed, the move to potentially auction Waystar could test the market's appetite for software investments. The company is attempting to navigate challenging market conditions, which have been exacerbated by a broader industry downturn.
Neither Waystar nor Evercore have commented on the potential sale. Similarly, representatives from EQT, CPPIB, and BlackRock have either declined to comment or have not responded to requests for comment.
The outcome of this strategic exploration could significantly impact Waystar's future, as it seeks to stabilize its position amidst evolving market dynamics and investor expectations.